Last reviewed · How we verify

NCT07221903: LAM

The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA

Recruiting now Last updated 4 November 2025
What this trial tests

trial in Regional Anesthesia in 10 participants. Currently enrolling.

Timeline
22 October 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorUniversity of Washington
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment10
Start date22 October 2025
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across United States

Conditions studied

Sponsor

University of Washington

Who can join

18 and older, any sex, with Regional Anesthesia or Burn. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Skin donor sites in patients undergoing split-thickness skin grafting surgeries can be very painful postoperatively. This site is most often the anterolateral thigh, the pain at which location can traditionally be covered by a fascia iliaca nerve block, although that comes with the disadvantage of losing motor functions in the femoral nerve distribution. The LAM nerve block, which is relatively new, aims to provide analgesia in the distribution of the lateral and anterior femoral cutaneous nerves. In short, this nerve block would decrease the sensation of the anterolateral thigh area without affecting the motor function of the leg. Investigators aim to study the consistency and coverage size of sensation changes by mapping out the area after the block in each patient.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Regional Anesthesia

Currently open trials in the same condition.

Other University of Washington trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07221903.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing